StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) shareholders

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.01+0.03 (+3.30%)

Close on Nov 17, 2026Market cap $19.46MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
5.8%
1M of 19M shares
Institutional holders
27
7 new, 6 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
11 buys · 0 sales
Net bought $300.53K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Opko Health, Inc.
Joint filing with Frost Phillip Md Et Al (13.90%), Frost Gamma Investments Trust (13.60%)
5,692,91629.60%13D (active) amendmentNov 4, 2026
Phillip Frost, M.D.
Joint filing with Frost Gamma Investments Trust (13.50%)
2,784,71913.90%13D (active) amendmentAug 3, 2026
Sabby Volatility Warrant Master Fund, Ltd.––13G (passive) amendmentDec 31, 2023

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of COCPValueChange% of portfolio
Vanguard Capital Management LLC358,2281.86%$376.14K+118,2570.00%
Renaissance Technologies LLC179,6280.93%$188.61K+55,7000.00%
Two Sigma Investments, LP175,3790.91%$184.15KNew0.00%
Geode Capital Management, LLC76,2080.40%$80.03K−14,0230.00%
BlackRock, Inc.73,7460.38%$77.43K–0.00%
Citadel Advisors LLC45,1180.23%$47.37KNew0.00%
Neuberger Berman Group LLC31,8860.17%$33.48K–0.00%
XTX Topco Ltd29,3420.15%$30.81K−6,6890.00%
Jane Street Group, LLC25,7610.13%$27.05K+13,0500.00%
Vanguard Fiduciary Trust Co24,0160.12%$25.22K–0.00%
State Street Corp20,5430.11%$21.57K–0.00%
Hrt Financial LP20,3360.11%$21.00KNew0.00%
Parallel Advisors, LLC12,5690.07%$13.20K–0.00%
Northern Trust Corp11,9210.06%$12.52K–0.00%
Ground Swell Capital, LLC10,7520.06%$11.29KNew0.01%
Wells Fargo & Company/Mn6,2570.03%$6.57K−7820.00%
UBS Group AG4,1330.02%$4.34K−5110.00%
Tower Research Capital LLC (TRC)3,9840.02%$4.18K−2640.00%
Morgan Stanley8710.00%$915−770.00%
Northwestern Mutual Wealth Management Co8170.00%$858–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026271M5.8%7 / 37 / 60M0M
Q1 2026261M4.0%4 / 64 / 40M0M
Q4 2025281M4.0%7 / 39 / 10M0M
Q3 2025221M3.5%4 / 35 / 40M0M
Q2 2025221M3.6%1 / 64 / 30M0M
Q1 2025241M3.9%2 / 55 / 20M0M
Q4 2024241M3.7%5 / 45 / 10M0M
Q3 2024201M3.7%7 / 42 / 00M0M
Q2 2024141M3.5%1 / 36 / 30M0M
Q1 2024161M4.4%0 / 83 / 10M0M
Q4 2023171M3.9%2 / 44 / 10M0M
Q3 2023161M3.7%0 / 63 / 40M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

6 funds held COCP in Q2 2026, 83% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of COCPValue% of fundAs of
Vanguard Total Stock Market Index Fund187,2660.97%$196.63K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund170,9620.89%$179.51K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund49,8070.26%$55.78K0.00%May 31, 2026
Fidelity Series Total Market Index Fund9,6290.05%$10.78K0.00%May 31, 2026
Fidelity Total Market Index Fund8,5260.04%$9.55K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund6,1220.03%$6.86K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
James SapirsteinChief Executive Officer––Jun 3, 2026
James Joseph MartinCo-CEO and CFO44,1670.23%Jan 13, 2026
Sam LeePresident and Co-CEO76,3550.40%Jan 13, 2026
Carol L. BrosgartDirector––Aug 21, 2026
Phillip Md Et Al FrostDirector, 10% owner2,020,65110.49%Aug 6, 2026
Anthony J. JapourDirector14,9240.08%Jan 13, 2026
Fred HassanDirector1,383,0097.18%Jan 13, 2026
Richard C. Pfenniger JrDirector31,4000.16%Jan 13, 2026
Roger D. KornbergDirector67,8780.35%Jan 13, 2026
Steven D. RubinDirector7,206,23537.41%Jan 13, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Phillip Md Et Al Frost
Director, 10% owner
Aug 5, 2026Buy+10,000$0.98$9.80K1,993,551
Phillip Md Et Al Frost
Director, 10% owner
Aug 3, 2026Buy+75,000$0.94$70.50K1,983,551
Phillip Md Et Al Frost
Director, 10% owner
Feb 24, 2026Buy+20,000$1.00$20.00K1,908,551
Phillip Md Et Al Frost
Director, 10% owner
Feb 6, 2026Buy+50,000$0.95$47.50K1,888,551
Phillip Md Et Al Frost
Director, 10% owner
Dec 31, 2025Buy+50,000$0.95$47.50K1,838,551
Phillip Md Et Al Frost
Director, 10% owner
Dec 30, 2025Buy+20,000$0.97$19.40K1,788,551
Phillip Md Et Al Frost
Director, 10% owner
Dec 26, 2025Buy+40,000$0.97$38.80K1,768,551
Phillip Md Et Al Frost
Director, 10% owner
Dec 24, 2025Buy+25,000$0.97$24.25K1,728,551
Phillip Md Et Al Frost
Director, 10% owner
Nov 26, 2025Buy+1,500$1.00$1.50K1,701,051
Phillip Md Et Al Frost
Director, 10% owner
Nov 26, 2025Buy+2,500$0.99$2.48K1,703,551
Phillip Md Et Al Frost
Director, 10% owner
Nov 25, 2025Buy+20,000$0.94$18.80K1,699,551
Phillip Md Et Al Frost
Director, 10% owner
Oct 28, 2025Award+359,713$1.39$500.00K1,679,551
Richard C. Pfenniger Jr
Director
Oct 28, 2025Award+20,000––31,400
Fred Hassan
Director
Oct 28, 2025Award+359,713$1.39$500.00K1,383,009
James Joseph Martin
Co-CEO and CFO
Oct 28, 2025Award+3,598$1.39$5.00K44,167
Sam Lee
President and Co-CEO
Oct 9, 2024Award+40,000––76,355
James Joseph Martin
Co-CEO and CFO
Oct 9, 2024Award+40,000––40,569
Fred Hassan
Director
Oct 9, 2024Award+8,067––1,023,296
Steven D. Rubin
Director
Oct 9, 2024Award+18,957––2,660,242
Phillip Md Et Al Frost
Director, 10% owner
Oct 9, 2024Award+27,100––27,100
Roger D. Kornberg
Director
Oct 9, 2024Award+28,109––28,109
Anthony J. Japour
Director
Oct 9, 2024Award+14,924––14,924
Richard C. Pfenniger Jr
Director
Oct 9, 2024Award+8,067––11,400
Phillip Md Et Al Frost
Director, 10% owner
Apr 4, 2023Buy+1,015,229$1.97$2.00M1,319,838
Richard C. Pfenniger Jr
Director
Aug 20, 2021Buy+40,000$1.03$41.20K40,000
Raymond F. Schinazi
10% owner
May 4, 2021Sale−575,000$2.95$1.70M7,674,960
Raymond F. Schinazi
10% owner
Oct 25, 2019Buy+7,906$1.15$9.09K9,257,863
Raymond F. Schinazi
10% owner
Oct 24, 2019Buy+5,094$1.15$5.86K9,249,957
Raymond F. Schinazi
10% owner
Oct 23, 2019Buy+3,935$1.04$4.09K9,244,863
Raymond F. Schinazi
Director, 10% owner
May 10, 2018Option exercise+263,158$1.90$500.00K985,384
Raymond F. Schinazi
Director, 10% owner
May 10, 2018Award+10,209$1.90$19.40K995,593
Raymond F. Schinazi
Director, 10% owner
May 3, 2018Award+420,737$1.90$799.40K722,226
Phillip Md Et Al Frost
Director, 10% owner
May 3, 2018Award+105,263$1.90$200.00K3,655,265
Raymond F. Schinazi
Director, 10% owner
Jul 11, 2017Option exercise+1,706,978$0.05$85.35K277,227,831
Raymond F. Schinazi
Director, 10% owner
Apr 20, 2017Award+4,166,667$0.24$1.00M9,044,717
Sam Lee
PRESIDENT
Dec 23, 2016Sale−2,200,000$0.44$968.00K13,087,847
Gary Wilcox
INTERIM CEO, Director
Sep 1, 2016Buy+10,000$0.41$4.10K16,948,605
Raymond F. Schinazi
Director, 10% owner
Sep 1, 2016Buy+4,878,050$0.41$2.00M4,878,050
David S. Block
Director
Sep 1, 2016Buy+10,000$0.41$4.10K168,696
Steven D. Rubin
Director
Mar 15, 2016Buy+39,216$0.51$20.00K733,484
David S. Block
Director
Mar 15, 2016Buy+50,000$0.51$25.50K158,696
Jane Ph D. Hsiao
Director
Mar 15, 2016Buy+1,235,294$0.51$630.00K3,435,294
Phillip Md Et Al Frost
Director, 10% owner
Mar 15, 2016Buy+2,941,177$0.51$1.50M106,500,147
Jeffrey A. Meckler
CHIEF EXECUTIVE OFFICER, Director
Mar 15, 2016Buy+294,118$0.51$150.00K657,161
Steven D. Rubin
Director
Mar 15, 2016Buy+39,216$0.51$20.00K93,564
Raymond F. Schinazi
Director, 10% owner
Mar 15, 2016Buy+2,941,176$0.51$1.50M275,520,853
Gary Wilcox
Director
Mar 15, 2016Buy+49,020$0.51$25.00K16,938,605
Jeffrey A. Meckler
CHIEF EXECUTIVE OFFICER, Director
Dec 23, 2015Buy+100,000$0.58$58.00K363,043
Raymond F. Schinazi
Director, 10% owner
Apr 21, 2015Buy+3,464,855$0.92$3.19M272,579,677
Jeffrey A. Meckler
Director
Mar 25, 2015Buy+163,043$0.92$150.00K263,043
Steven D. Rubin
Director
Mar 25, 2015Buy+54,348$0.92$50.00K694,268
David S. Block
Director
Mar 25, 2015Buy+108,696$0.92$100.00K108,696
Gamma Investments Trust Frost
10% owner
Mar 25, 2015Buy+3,464,855$0.92$3.19M103,558,969
Jane Ph D. Hsiao
Director
Mar 25, 2015Buy+2,200,000$0.92$2.02M2,200,000
Gary Wilcox
CHIEF EXECUTIVE OFFICER, Director
Mar 25, 2015Buy+54,348$0.92$50.00K16,889,585
Phillip Md Et Al Frost
Director, 10% owner
Mar 3, 2015Option exercise+87,726,389––100,094,114
Jane Ph D. Hsiao
Director
Mar 3, 2015Option exercise+5,496,654––5,496,654
Raymond F. Schinazi
Director, 10% owner
Mar 3, 2015Option exercise+269,114,822––269,114,822
Sam Lee
PRESIDENT
Mar 3, 2015Option exercise+15,287,847––15,287,847
Gary Wilcox
CHIEF EXECUTIVE OFFICER, Director
Mar 3, 2015Option exercise+16,835,237––16,835,237

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
2.37%
0M shares short
Days to cover
4.9
At 0M shares a day
Change since last report
+1.2%
From 0M shares
Short volume, 20 days
37.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cocrystal Pharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 7,479 shares on Sep 3, 2026 over the last 90 days.

See a number that looks wrong?